Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
-
Shares outstanding
-
239,647,920
-
Total 13F shares
-
33,416,255
-
Share change
-
-1,069,106
-
Total reported value
-
$4,980,080,985
-
Put/Call ratio
-
144%
-
Price per share
-
$149.10
-
Number of holders
-
276
-
Value change
-
-$212,346,370
-
Number of buys
-
117
-
Number of sells
-
131
Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q2 2022
As of 30 Jun 2022 BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) had 276 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 33,416,255 shares of stock of the company.
Largest 10 holders included BAILLIE GIFFORD & CO, PRIMECAP MANAGEMENT CO/CA/, FLOSSBACH VON STORCH AG, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., Fosun International Ltd, Capital World Investors, Artisan Partners Limited Partnership, DEUTSCHE BANK AG\, and PICTET ASSET MANAGEMENT SA.
This table shows 276 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.